Skip to main content
. 2023 Nov 29;136(24):2931–2937. doi: 10.1097/CM9.0000000000002939

Figure 3.

Figure 3

Serum lipid change 1 year after switching to TAF/FTC/BIC among subcategories receiving TAF/FTC/EVG/c at baseline. BIC: Bictegravir sodium; EVG/c: Elvitegravir/cobicistat; FTC: Emtricitabine; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; TAF: Tenofovir alafenamide; TC: Total cholesterol; TG: Triglyceride.